Header Logo

Connection

Alan Go to Risk Factors

Back to Details
This is a "connection" page, showing publications Alan Go has written about Risk Factors.
Alan Go
Connection Strength
6.081
Risk Factors
  1. Incident Atrial Fibrillation and Risk of Dementia in a Diverse, Community-Based Population. J Am Heart Assoc. 2023 03 21; 12(6):e028290.
    View in: PubMed
    Score: 0.131
  2. Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis. Am Heart J. 2023 02; 256:60-72.
    View in: PubMed
    Score: 0.128
  3. Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study. J Am Heart Assoc. 2021 10 19; 10(20):e020377.
    View in: PubMed
    Score: 0.119
  4. Noncardiac-Related Morbidity, Mobility Limitation, and Outcomes in Older Adults With Heart Failure. J Gerontol A Biol Sci Med Sci. 2020 09 25; 75(10):1981-1988.
    View in: PubMed
    Score: 0.111
  5. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations. Circ Cardiovasc Qual Outcomes. 2020 09; 13(9):e006415.
    View in: PubMed
    Score: 0.110
  6. Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction. J Am Heart Assoc. 2020 03 17; 9(6):e014415.
    View in: PubMed
    Score: 0.106
  7. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI. Clin J Am Soc Nephrol. 2020 01 07; 15(1):26-34.
    View in: PubMed
    Score: 0.105
  8. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol. 2020 02 15; 125(4):534-541.
    View in: PubMed
    Score: 0.104
  9. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease. JAMA Intern Med. 2018 03 01; 178(3):390-398.
    View in: PubMed
    Score: 0.093
  10. Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department. West J Emerg Med. 2018 Mar; 19(2):346-360.
    View in: PubMed
    Score: 0.092
  11. Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. Am Heart J. 2017 Dec; 194:25-38.
    View in: PubMed
    Score: 0.089
  12. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart. 2017 04; 103(7):529-537.
    View in: PubMed
    Score: 0.084
  13. Cardiovascular Disease Consequences of CKD. Semin Nephrol. 2016 07; 36(4):293-304.
    View in: PubMed
    Score: 0.083
  14. Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization. Med Care. 2016 Apr; 54(4):365-72.
    View in: PubMed
    Score: 0.081
  15. High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults. Heart. 2016 08 01; 102(15):1177-82.
    View in: PubMed
    Score: 0.081
  16. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease. J Hypertens. 2016 Feb; 34(2):244-52.
    View in: PubMed
    Score: 0.080
  17. Elevated BP after AKI. J Am Soc Nephrol. 2016 Mar; 27(3):914-23.
    View in: PubMed
    Score: 0.077
  18. Coronary artery bypass grafting and percutaneous coronary intervention in patients with end-stage renal disease. Eur J Cardiothorac Surg. 2015 May; 47(5):e193-8.
    View in: PubMed
    Score: 0.076
  19. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):49-58.
    View in: PubMed
    Score: 0.074
  20. The association of gender to cardiovascular outcomes after coronary artery revascularization in patients with end-stage renal disease. Clin Cardiol. 2014 Sep; 37(9):546-51.
    View in: PubMed
    Score: 0.072
  21. Intersection of cardiovascular disease and kidney disease: atrial fibrillation. Curr Opin Nephrol Hypertens. 2014 May; 23(3):275-82.
    View in: PubMed
    Score: 0.071
  22. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):399-410.
    View in: PubMed
    Score: 0.070
  23. Incremental prognostic information from kidney function in patients with new onset coronary heart disease. Am Heart J. 2014 Jan; 167(1):86-92.
    View in: PubMed
    Score: 0.068
  24. Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure. Circ Cardiovasc Qual Outcomes. 2013 Sep 01; 6(5):525-33.
    View in: PubMed
    Score: 0.068
  25. Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Circ Heart Fail. 2013 Jul; 6(4):635-46.
    View in: PubMed
    Score: 0.067
  26. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann Intern Med. 2013 May 21; 158(10):727-34.
    View in: PubMed
    Score: 0.066
  27. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes. 2013 May 01; 6(3):333-42.
    View in: PubMed
    Score: 0.066
  28. Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. Am Heart J. 2013 May; 165(5):800-8, 808.e1-2.
    View in: PubMed
    Score: 0.066
  29. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013 Feb 05; 127(5):569-74.
    View in: PubMed
    Score: 0.065
  30. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):e6-e245.
    View in: PubMed
    Score: 0.065
  31. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke. 2012 Oct; 43(10):2788-90.
    View in: PubMed
    Score: 0.063
  32. Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol. 2011 Oct 04; 58(15):1600-7.
    View in: PubMed
    Score: 0.059
  33. Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study. BMC Nephrol. 2011 Sep 14; 12:44.
    View in: PubMed
    Score: 0.059
  34. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011 Sep; 118(3):583-91.
    View in: PubMed
    Score: 0.059
  35. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
    View in: PubMed
    Score: 0.058
  36. Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol. 2011 Feb; 6(2):248-56.
    View in: PubMed
    Score: 0.055
  37. CHA2DS2-VASc risk scheme: not ready for clinical use. Chest. 2010 Oct; 138(4):1020; author reply 1020-1.
    View in: PubMed
    Score: 0.055
  38. Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities. Arch Intern Med. 2010 May 10; 170(9):759-64.
    View in: PubMed
    Score: 0.054
  39. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009 Sep 01; 151(5):297-305.
    View in: PubMed
    Score: 0.051
  40. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Circ Cardiovasc Qual Outcomes. 2009 Jul; 2(4):297-304.
    View in: PubMed
    Score: 0.051
  41. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol. 2009 May; 4(5):891-8.
    View in: PubMed
    Score: 0.050
  42. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009 Mar 17; 119(10):1363-9.
    View in: PubMed
    Score: 0.050
  43. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009 Feb 23; 169(4):342-50.
    View in: PubMed
    Score: 0.050
  44. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1487-93.
    View in: PubMed
    Score: 0.048
  45. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke. 2008 Jun; 39(6):1901-10.
    View in: PubMed
    Score: 0.047
  46. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008 Jul; 74(1):101-7.
    View in: PubMed
    Score: 0.047
  47. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007 Aug 15; 100(4):690-6.
    View in: PubMed
    Score: 0.044
  48. Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol. 2006 Dec 15; 164(12):1150-9.
    View in: PubMed
    Score: 0.042
  49. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006 Oct; 17(10):2892-9.
    View in: PubMed
    Score: 0.042
  50. Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease. Curr Opin Nephrol Hypertens. 2006 May; 15(3):296-302.
    View in: PubMed
    Score: 0.041
  51. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006 Feb 21; 144(4):229-38.
    View in: PubMed
    Score: 0.040
  52. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006 Jan 03; 144(1):21-8.
    View in: PubMed
    Score: 0.040
  53. The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int. 2005 Nov; 68(5):2310-6.
    View in: PubMed
    Score: 0.039
  54. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005 Sep 20; 112(12):1687-91.
    View in: PubMed
    Score: 0.039
  55. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005 Mar-Apr; 14(2):56-61.
    View in: PubMed
    Score: 0.038
  56. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 09 23; 351(13):1296-305.
    View in: PubMed
    Score: 0.036
  57. Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice. Am J Manag Care. 2004 Apr; 10(3 Suppl):S58-65.
    View in: PubMed
    Score: 0.035
  58. Gaps in guideline-recommended anticoagulation in patients with atrial fibrillation and elevated thromboembolic risk within an integrated healthcare delivery system. BMC Cardiovasc Disord. 2023 11 21; 23(1):578.
    View in: PubMed
    Score: 0.034
  59. Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study. Ann Intern Med. 2023 07; 176(7):961-968.
    View in: PubMed
    Score: 0.034
  60. Proteomic cardiovascular risk assessment in chronic kidney disease. Eur Heart J. 2023 06 20; 44(23):2095-2110.
    View in: PubMed
    Score: 0.033
  61. Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients. J Lipid Res. 2023 Jun; 64(6):100381.
    View in: PubMed
    Score: 0.033
  62. Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Thromb Thrombolysis. 2003 Feb; 15(1):41-6.
    View in: PubMed
    Score: 0.033
  63. Predicting Cardiovascular Events after Sepsis with?Death as a Competing Risk. Ann Am Thorac Soc. 2023 01; 20(1):145-148.
    View in: PubMed
    Score: 0.032
  64. Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system. BMC Cardiovasc Disord. 2022 12 23; 22(1):566.
    View in: PubMed
    Score: 0.032
  65. ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor. Am Heart J. 2022 07; 249:76-85.
    View in: PubMed
    Score: 0.031
  66. Deoxycholic Acid and Coronary Artery Calcification in the Chronic Renal Insufficiency Cohort. J Am Heart Assoc. 2022 Apr 05; 11(7):e022891.
    View in: PubMed
    Score: 0.031
  67. Change in ankle-brachial index and mortality among individuals with chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2021 12 02; 36(12):2224-2231.
    View in: PubMed
    Score: 0.030
  68. Antithrombotic therapy in atrial fibrillation. Clin Geriatr Med. 2001 Feb; 17(1):131-47.
    View in: PubMed
    Score: 0.028
  69. A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2021 02; 99(2):456-465.
    View in: PubMed
    Score: 0.027
  70. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation. 2000 Jul 04; 102(1):11-3.
    View in: PubMed
    Score: 0.027
  71. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure. J Am Heart Assoc. 2020 07 07; 9(13):e014385.
    View in: PubMed
    Score: 0.027
  72. Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study. Br J Ophthalmol. 2021 02; 105(2):246-252.
    View in: PubMed
    Score: 0.027
  73. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999 Dec 21; 131(12):927-34.
    View in: PubMed
    Score: 0.026
  74. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2019 12; 12(12):e007612.
    View in: PubMed
    Score: 0.026
  75. Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020 03; 75(3):394-403.
    View in: PubMed
    Score: 0.026
  76. Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e006212.
    View in: PubMed
    Score: 0.026
  77. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study. Clin Chem. 2019 11; 65(11):1448-1457.
    View in: PubMed
    Score: 0.026
  78. Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. Ann Intern Med. 1998 Nov 01; 129(9):690-7.
    View in: PubMed
    Score: 0.024
  79. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart. 2018 11; 104(22):1850-1858.
    View in: PubMed
    Score: 0.024
  80. Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury. Kidney Int. 2018 04; 93(4):968-976.
    View in: PubMed
    Score: 0.023
  81. Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. J Am Coll Cardiol. 2017 Sep 12; 70(11):1325-1335.
    View in: PubMed
    Score: 0.022
  82. Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort). Arterioscler Thromb Vasc Biol. 2017 10; 37(10):1971-1978.
    View in: PubMed
    Score: 0.022
  83. Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1795-1803.
    View in: PubMed
    Score: 0.022
  84. Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension. 2017 08; 70(2):435-443.
    View in: PubMed
    Score: 0.022
  85. Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry. Eur Heart J Qual Care Clin Outcomes. 2017 07 01; 3(3):192-197.
    View in: PubMed
    Score: 0.022
  86. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. Clin Cardiol. 2017 Sep; 40(9):746-751.
    View in: PubMed
    Score: 0.022
  87. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clin J Am Soc Nephrol. 2017 May 08; 12(5):761-771.
    View in: PubMed
    Score: 0.022
  88. Loss of executive function after dialysis initiation in adults with chronic kidney disease. Kidney Int. 2017 04; 91(4):948-953.
    View in: PubMed
    Score: 0.021
  89. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study. J Am Geriatr Soc. 2017 01; 65(1):35-41.
    View in: PubMed
    Score: 0.021
  90. How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation? Am J Cardiol. 2016 09 01; 118(5):697-9.
    View in: PubMed
    Score: 0.021
  91. Multimorbidity is strongly associated with long-term but not short-term mortality after cardiac valve replacement. Int J Cardiol. 2016 Jul 15; 215:417-21.
    View in: PubMed
    Score: 0.020
  92. Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clin J Am Soc Nephrol. 2016 07 07; 11(7):1189-96.
    View in: PubMed
    Score: 0.020
  93. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol Dial Transplant. 2016 10; 31(10):1662-9.
    View in: PubMed
    Score: 0.020
  94. Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation. Eur Heart J. 2016 Nov 07; 37(42):3203-3210.
    View in: PubMed
    Score: 0.020
  95. Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal Disease. Am J Cardiol. 2016 May 15; 117(10):1596-1603.
    View in: PubMed
    Score: 0.020
  96. Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One. 2016; 11(2):e0148189.
    View in: PubMed
    Score: 0.020
  97. Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study. J Am Coll Cardiol. 2016 Jan 26; 67(3):239-47.
    View in: PubMed
    Score: 0.020
  98. Cardiac outcomes after regional or general anesthesia. Do we have the answer? Anesthesiology. 1996 Jan; 84(1):1-2.
    View in: PubMed
    Score: 0.020
  99. Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry. Clin Cardiol. 2016 Feb; 39(2):119-25.
    View in: PubMed
    Score: 0.020
  100. Prevalence and Correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1757-66.
    View in: PubMed
    Score: 0.020
  101. Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD. J Am Soc Nephrol. 2016 Feb; 27(2):559-69.
    View in: PubMed
    Score: 0.019
  102. Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network. J Am Heart Assoc. 2015 Jun 02; 4(6):e002005.
    View in: PubMed
    Score: 0.019
  103. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study. Circ Heart Fail. 2015 Jul; 8(4):702-8.
    View in: PubMed
    Score: 0.019
  104. Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization. Am Heart J. 2015 Aug; 170(2):400-8.
    View in: PubMed
    Score: 0.019
  105. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2015 Sep; 30(9):1534-41.
    View in: PubMed
    Score: 0.019
  106. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. Am Heart J. 2015 Jul; 170(1):141-8, 148.e1.
    View in: PubMed
    Score: 0.019
  107. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Aug; 66(2):266-73.
    View in: PubMed
    Score: 0.019
  108. The complex relationship of race to outcomes in heart failure with preserved ejection fraction. Am J Med. 2015 Jun; 128(6):591-600.
    View in: PubMed
    Score: 0.019
  109. Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States. J Am Heart Assoc. 2014 Dec 03; 3(6):e001097.
    View in: PubMed
    Score: 0.018
  110. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study. Am J Nephrol. 2014; 40(5):399-407.
    View in: PubMed
    Score: 0.018
  111. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts). Am J Cardiol. 2015 Jan 01; 115(1):40-6.
    View in: PubMed
    Score: 0.018
  112. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Feb; 65(2):267-74.
    View in: PubMed
    Score: 0.018
  113. Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension. 2015 Jan; 65(1):93-100.
    View in: PubMed
    Score: 0.018
  114. Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. Am J Cardiol. 2014 Aug 15; 114(4):583-6.
    View in: PubMed
    Score: 0.018
  115. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circulation. 2014 May 20; 129(20):2005-12.
    View in: PubMed
    Score: 0.018
  116. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 May; 167(5):735-42.e2.
    View in: PubMed
    Score: 0.018
  117. Lone atrial fibrillation: does it exist? J Am Coll Cardiol. 2014 May 06; 63(17):1715-23.
    View in: PubMed
    Score: 0.017
  118. Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study. BMC Nephrol. 2013 Dec 05; 14:268.
    View in: PubMed
    Score: 0.017
  119. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2014 Feb; 63(2):236-43.
    View in: PubMed
    Score: 0.017
  120. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014 Feb; 25(2):349-60.
    View in: PubMed
    Score: 0.017
  121. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol. 2013 Oct 22; 14:229.
    View in: PubMed
    Score: 0.017
  122. Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013; 38(4):307-15.
    View in: PubMed
    Score: 0.017
  123. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):461-9.
    View in: PubMed
    Score: 0.017
  124. Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort). J Am Coll Cardiol. 2013 Aug 27; 62(9):789-98.
    View in: PubMed
    Score: 0.017
  125. A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013 Mar; 8(3):355-62.
    View in: PubMed
    Score: 0.016
  126. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Feb 01; 2(1):e005694.
    View in: PubMed
    Score: 0.016
  127. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 2013 Jan 15; 127(2):224-32.
    View in: PubMed
    Score: 0.016
  128. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013 Jan; 45(1):25-33.
    View in: PubMed
    Score: 0.016
  129. Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). Am J Cardiol. 2012 Dec 15; 110(12):1735-41.
    View in: PubMed
    Score: 0.016
  130. Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol. 2012 Sep; 130(9):1136-44.
    View in: PubMed
    Score: 0.016
  131. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012 Oct; 23(10):1725-34.
    View in: PubMed
    Score: 0.016
  132. Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. Stroke. 2012 Jul; 43(7):1795-9.
    View in: PubMed
    Score: 0.015
  133. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e531S-e575S.
    View in: PubMed
    Score: 0.015
  134. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):e2-e220.
    View in: PubMed
    Score: 0.015
  135. Ethnic differences in the development of albuminuria: the DISTANCE study. Am J Manag Care. 2011 Nov; 17(11):737-45.
    View in: PubMed
    Score: 0.015
  136. Cardiovascular disease among hispanics and non-hispanics in the chronic renal insufficiency cohort (CRIC) study. Clin J Am Soc Nephrol. 2011 Sep; 6(9):2121-31.
    View in: PubMed
    Score: 0.015
  137. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011 Jul 19; 58(4):395-401.
    View in: PubMed
    Score: 0.015
  138. Racial variation in lipoprotein-associated phospholipase A2 in older adults. BMC Cardiovasc Disord. 2011 Jun 29; 11:38.
    View in: PubMed
    Score: 0.015
  139. CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies. Am J Kidney Dis. 2011 Aug; 58(2):214-27.
    View in: PubMed
    Score: 0.015
  140. Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):726-31.
    View in: PubMed
    Score: 0.014
  141. Ankle brachial index screening in asymptomatic older adults. Am Heart J. 2011 May; 161(5):979-85.
    View in: PubMed
    Score: 0.014
  142. Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. J Cardiovasc Magn Reson. 2010 Dec 30; 12:75.
    View in: PubMed
    Score: 0.014
  143. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol. 2010 Nov 02; 56(19):1552-63.
    View in: PubMed
    Score: 0.014
  144. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011 Jan 04; 154(1):1-11.
    View in: PubMed
    Score: 0.014
  145. Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010 Nov; 3(6):624-31.
    View in: PubMed
    Score: 0.014
  146. Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent). Circ Cardiovasc Interv. 2010 Jun 01; 3(3):230-5.
    View in: PubMed
    Score: 0.013
  147. Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):261-6.
    View in: PubMed
    Score: 0.013
  148. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):303-8.
    View in: PubMed
    Score: 0.013
  149. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23; 121(7):948-54.
    View in: PubMed
    Score: 0.013
  150. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010 Feb; 58(2):338-45.
    View in: PubMed
    Score: 0.013
  151. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23; 121(7):e46-e215.
    View in: PubMed
    Score: 0.013
  152. Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities. Clin Chem. 2010 Jan; 56(1):111-20.
    View in: PubMed
    Score: 0.013
  153. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 2009 Oct; 76(8):893-9.
    View in: PubMed
    Score: 0.013
  154. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009 Aug; 4(8):1302-11.
    View in: PubMed
    Score: 0.013
  155. Statin use and risk of basal cell carcinoma. J Am Acad Dermatol. 2009 Jul; 61(1):66-72.
    View in: PubMed
    Score: 0.013
  156. Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J. 2009 May; 157(5):939-45.
    View in: PubMed
    Score: 0.013
  157. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009 Feb 03; 119(4):606-18.
    View in: PubMed
    Score: 0.012
  158. Chronic kidney disease in United States Hispanics: a growing public health problem. Ethn Dis. 2009; 19(4):466-72.
    View in: PubMed
    Score: 0.012
  159. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):546S-592S.
    View in: PubMed
    Score: 0.012
  160. Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet. 2008 May; 123(4):399-408.
    View in: PubMed
    Score: 0.012
  161. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society. Circulation. 2008 Feb 26; 117(8):1101-20.
    View in: PubMed
    Score: 0.012
  162. A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. Atherosclerosis. 2008 May; 198(1):136-44.
    View in: PubMed
    Score: 0.011
  163. Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. J Cardiopulm Rehabil Prev. 2007 Jul-Aug; 27(4):227-32.
    View in: PubMed
    Score: 0.011
  164. Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study. Ann Epidemiol. 2007 Sep; 17(9):669-78.
    View in: PubMed
    Score: 0.011
  165. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007 Feb 06; 115(5):e69-171.
    View in: PubMed
    Score: 0.011
  166. Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab. 2007 Feb; 92(2):729-32.
    View in: PubMed
    Score: 0.011
  167. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. Clin J Am Soc Nephrol. 2007 Jan; 2(1):81-8.
    View in: PubMed
    Score: 0.011
  168. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? J Am Coll Cardiol. 2006 Nov 07; 48(9):1800-7.
    View in: PubMed
    Score: 0.011
  169. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc. 2006 Aug; 54(8):1231-6.
    View in: PubMed
    Score: 0.010
  170. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council. Circulation. 2006 Jul 11; 114(2):168-82.
    View in: PubMed
    Score: 0.010
  171. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol. 2005 Jun; 32(6):1076-80.
    View in: PubMed
    Score: 0.010
  172. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005 Apr 25; 165(8):923-8.
    View in: PubMed
    Score: 0.010
  173. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004 Nov 16; 141(10):745-52.
    View in: PubMed
    Score: 0.009
  174. Gender and risk of adverse outcomes in heart failure. Am J Cardiol. 2004 Nov 01; 94(9):1147-52.
    View in: PubMed
    Score: 0.009
  175. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):429S-456S.
    View in: PubMed
    Score: 0.009
  176. Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt). 2004 May; 13(4):381-9; discussion 390-2.
    View in: PubMed
    Score: 0.009
  177. Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attack. Arch Neurol. 2002 Sep; 59(9):1437-41.
    View in: PubMed
    Score: 0.008
  178. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. J Am Coll Cardiol. 2001 Nov 01; 38(5):1297-301.
    View in: PubMed
    Score: 0.007
  179. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 2001 Sep 18; 135(6):393-400.
    View in: PubMed
    Score: 0.007
  180. Prediction of risk for patients with unstable angina. Evid Rep Technol Assess (Summ). 2000 Aug; (31):1-3.
    View in: PubMed
    Score: 0.007
  181. Clinical symptoms and myocardial infarction in left bundle branch block patients. Cardiology. 2000; 93(1-2):100-4.
    View in: PubMed
    Score: 0.007

© 2024 Kaiser Permanente